Unjha Formulations Q3 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
23.29
-0.10 (-0.43%)
-0.10 (-0.43%)Volume101.00
Updated: Fri 13 Feb, 2026 | 11:25:27
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹4.41 Cr.(17.15%)
- Operating Profit₹0.21 Cr.(-2.28%)
- Profit After Tax₹0.24 Cr.(7.01%)
- Operating Margin4.77%(-16.59%)
Note: Comparison is on YoY basis
Quarterly - Unjha Formulations Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4.20 | 3.91 | 18.97% | 5.15 | 18.33% |
| Depreciation/ Amortization | 0.04 | 0.02 | 44.01% | 0.02 | 78.60% |
| Operating Income | 0.21 | -0.13 | -72.25% | 0.39 | -2.28% |
| Net Income | 0.24 | -0.11 | -70.69% | 0.39 | 7.01% |
| Other Operating Expenses Total | 0.45 | 0.37 | -20.21% | 0.49 | 28.62% |
| Net Income Before Taxes | 0.24 | -0.11 | -70.69% | 0.39 | 7.01% |
| Total Revenue | 4.41 | 3.78 | 2.86% | 5.55 | 17.15% |
| Selling/ General/ Admin Expenses Total | 0.32 | 0.12 | 118.15% | 0.19 | 63.47% |
| Diluted Normalized EPS | 0.53 | -0.25 | -71.04% | 0.87 | 6.00% |